ICYMI: Quick ResMed Update

Philips is quietly dipping a toe back into the U.S. sleep apnea market. A precursor to a full relaunch in the U.S.?

Mar 25, 2026

∙ Paid

This is not the time to ignore red flags. Join the large and growing list – portfolio managers, analysts, private investors – who already have signed on as premium subscribers to my Red Flag Alerts for one reason: To understand what could go wrong before – not after – the news hits. Learn more here.

▶If you missed my quick ResMed RMD 0.00%↑ update yesterday on my chat…

Herb Greenberg | On the Street

ICYMI: Quick ResMed Update

Philips is quietly dipping a toe back into the U.S. sleep apnea market. A precursor to a full relaunch in the U.S.?

This post is for paid subscribers